Founded in 2005, Corealis Pharma is a premier CDMO company, specializing in oral solid dosage (OSD) formulation development and phase I/II and early Phase III clinical supply manufacturing for trials worldwide.
Browse our site to learn more about how we use our unique CDMO skill-set and specialized equipment to unlock the full potential of your drug product.
Corealis offers specialized expertise in oral solid dose clinical formulation development, with extended proficiency in cGMP clinical supply manufacturing. The company’s cutting-edge facilities can manage the most challenging formulation and manufacturing projects.
Corealis’ CDMO team develops high-quality, phase-appropriate drug products and includes using High-Potent Active Pharmaceutical Ingredients (HPAPI) to meet cGMP regulatory standards. The company achieves its primary aim of exceeding client expectations by prioritizing timely delivery, and executing on precise specifications.
Corealis is an accomplished Contract Development and Manufacturing Organization (CDMO), providing turnkey project specialists — managing and simplifying the development and manufacturing process of clients’ drug products.
Corealis is committed to the timely completion of project deliverables, ensuring client confidence. With our elite team, we are able to provide our expertise at any phase of the development process.
Corealis exhausts every option to ensure success. The team is renowned for giving promising APIs new life and revitalizing complex projects.
Stringent adherence to regulatory guidelines and robust scientific expertise assure that the drug formulation progresses smoothly throughout all phases of clinical development.
Corealis strives to go above and beyond to exceed client expectations by:
Corealis’ proven approach is cemented by the repeat business of trusted and reputable clients. With a commitment to providing leading development and cGMP manufacturing throughout the product journey, Corealis prides itself on being a reliable partner and is dedicated to meeting customer needs.
Corealis’ experts are ready to answer any queries about the company’s oral solid dose offering, including its development and manufacturing capabilities.
